US20080050807A1 - Gene encoding alkaline liquefying alpha-amylase - Google Patents
Gene encoding alkaline liquefying alpha-amylase Download PDFInfo
- Publication number
- US20080050807A1 US20080050807A1 US10/829,331 US82933104A US2008050807A1 US 20080050807 A1 US20080050807 A1 US 20080050807A1 US 82933104 A US82933104 A US 82933104A US 2008050807 A1 US2008050807 A1 US 2008050807A1
- Authority
- US
- United States
- Prior art keywords
- seq
- amylase
- dna molecule
- liquefying
- alkaline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108090000637 alpha-Amylases Proteins 0.000 title claims abstract description 74
- 102000004139 alpha-Amylases Human genes 0.000 title claims abstract description 63
- 229940024171 alpha-amylase Drugs 0.000 title claims abstract description 52
- 108090000623 proteins and genes Proteins 0.000 title claims description 38
- 108020004414 DNA Proteins 0.000 claims abstract description 40
- 108020004511 Recombinant DNA Proteins 0.000 claims abstract description 14
- 102000053602 DNA Human genes 0.000 claims description 19
- 239000002773 nucleotide Substances 0.000 claims description 19
- 125000003729 nucleotide group Chemical group 0.000 claims description 19
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 16
- 229920002472 Starch Polymers 0.000 claims description 15
- 235000019698 starch Nutrition 0.000 claims description 15
- 230000000694 effects Effects 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 230000001747 exhibiting effect Effects 0.000 claims description 8
- 150000001413 amino acids Chemical class 0.000 claims description 7
- 239000000872 buffer Substances 0.000 claims description 7
- 229920000856 Amylose Polymers 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 230000000295 complement effect Effects 0.000 claims description 3
- 238000001962 electrophoresis Methods 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 claims description 2
- 229920000945 Amylopectin Polymers 0.000 claims description 2
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 claims description 2
- -1 alkylbenzene sulfonates Chemical class 0.000 claims 6
- 239000011734 sodium Substances 0.000 claims 4
- 229910052708 sodium Inorganic materials 0.000 claims 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 2
- FTNIPWXXIGNQQF-UHFFFAOYSA-N Maltopentose Chemical compound OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(O)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O FTNIPWXXIGNQQF-UHFFFAOYSA-N 0.000 claims 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 2
- 238000001155 isoelectric focusing Methods 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 229920001218 Pullulan Polymers 0.000 claims 1
- 239000004373 Pullulan Substances 0.000 claims 1
- 150000005215 alkyl ethers Chemical class 0.000 claims 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 claims 1
- 239000007857 degradation product Substances 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 235000019423 pullulan Nutrition 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 239000000344 soap Substances 0.000 claims 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims 1
- CIJQGPVMMRXSQW-UHFFFAOYSA-M sodium;2-aminoacetic acid;hydroxide Chemical compound O.[Na+].NCC([O-])=O CIJQGPVMMRXSQW-UHFFFAOYSA-M 0.000 claims 1
- 239000012634 fragment Substances 0.000 abstract description 54
- 244000005700 microbiome Species 0.000 abstract description 22
- 238000000034 method Methods 0.000 abstract description 17
- 239000003599 detergent Substances 0.000 abstract description 9
- 239000004382 Amylase Substances 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 102000004190 Enzymes Human genes 0.000 description 21
- 108090000790 Enzymes Proteins 0.000 description 21
- 229940088598 enzyme Drugs 0.000 description 21
- 239000008107 starch Substances 0.000 description 14
- 239000013611 chromosomal DNA Substances 0.000 description 13
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 12
- 239000013612 plasmid Substances 0.000 description 9
- 239000013598 vector Substances 0.000 description 9
- 102000013142 Amylases Human genes 0.000 description 7
- 108010065511 Amylases Proteins 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 108091008146 restriction endonucleases Proteins 0.000 description 7
- 235000019418 amylase Nutrition 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- 229960000723 ampicillin Drugs 0.000 description 5
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 108700026244 Open Reading Frames Proteins 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 241001131785 Escherichia coli HB101 Species 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 108020005038 Terminator Codon Proteins 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 229940025131 amylases Drugs 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004851 dishwashing Methods 0.000 description 2
- IDQFMTPFABLANH-UHFFFAOYSA-L disodium 2-aminoacetic acid chloride hydroxide Chemical compound [OH-].[Na+].[Na+].[Cl-].NCC(O)=O IDQFMTPFABLANH-UHFFFAOYSA-L 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000007852 inverse PCR Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- LWFUFLREGJMOIZ-UHFFFAOYSA-N 3,5-dinitrosalicylic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O LWFUFLREGJMOIZ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001646716 Escherichia coli K-12 Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 241001495443 Natronococcus sp. Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 241000187180 Streptomyces sp. Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229940124568 digestive agent Drugs 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 210000000514 hepatopancreas Anatomy 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 235000020429 malt syrup Nutrition 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
- C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
Definitions
- the present invention relates to the gene encoding alkaline liquefying ⁇ -amylase and fragments thereof, and to recombinant DNA and a transformant bearing the gene or fragments of the gene.
- Alph ⁇ -amylase has long been used in a variety of fields. For example, it has been used for the saccharification of grains and potatoes in the fermentation industry, as starch paste removers in the textile industry, as digestives in the pharmaceutical industry, and for the manufacture of thick malt syrups in the food industry.
- Alph ⁇ -amylase is an enzyme which acts on a starch-related polysaccharides such as amylose and amylopectin, hydrolyzing solely the ⁇ -1,4-glucoside bond of the polysaccharide molecule.
- crystalline samples or electrophoretically homogeneous samples of ⁇ -amylase have been obtained from a number of different sources including bacteria, fungi, plant seeds, and animal digestive glands.
- alkaline ⁇ -amylases and alkali-resistant ⁇ -amylase include, an enzyme produced by Bacillus sp. A-40-2 [Horikoshi, K. et al., Agric. Biol. Chem., 35, 1783 (1971)], an enzyme produced by Bacillus sp. NRRL B-3881 [Boyer, E., J. Bacteriol., 110, 992 (1972)], an enzyme produced by Streptomyces sp. KSM-9 (Japanese Patent Application Laid-Open (kokai) No. 61-209528, an enzyme produced by Bacillus sp. H-167 (Japanese Patent Application Laid-Open (kokai) No.
- alkaline 60 -amylase refers to ⁇ -amylases whose optimum pHs fall within the alkaline pH range
- alkali-resistant ⁇ -amylase refers to ⁇ -amylases which have optimum pHs within the neutral to acidic range but whose activities in the alkaline range are comparable with those obtained at an optimum pH, and in addition, which retain their stabilities in the alkaline range.
- neutral range is meant the range of pH not less than 6 and less than 8
- alkaline denotes a pH which is higher than the “neutral range”.
- alkaline ⁇ -amylases and alkali-resistant amylases are so-called saccharifying ⁇ -amylases which decompose starch or starch-related polysaccharides to glucose, maltose, or maltotriose.
- these enzymes cause problems if they are used as enzymes for detergents, though they are advantageously used in the manufacture of sugar.
- alkaline liquefying ⁇ -amylases which exhibit resistance against surfactants used in detergents, and which decompose starch or starch-related polysaccharides in a highly random manner.
- the present inventors continued an extensive search for microorganisms producing an alkaline liquefying ⁇ -amylase suitable as a detergent component, and they discovered that an alkalophilic Bacillus sp. KSM-AP1378 strain, having its optimum pH for growth in the alkaline range, produces an enzyme exhibiting the activity of an alkaline liquefying ⁇ -amylase. They elucidated that this enzyme is useful as an additive in detergent compositions for washing dishes and kitchen utensils and for detergent compositions for clothes (W 0 94/26881).
- Amounts of the enzyme produced may be effectively increased by improving a method for culturing an alkaline liquefying ⁇ -amylase-producing microorganism, Bacillus sp. KSM-AP1378, or by exploiting mutation.
- a method for culturing an alkaline liquefying ⁇ -amylase-producing microorganism, Bacillus sp. KSM-AP1378 or by exploiting mutation.
- another approach must be taken.
- Amounts of an enzyme produced can be enhanced using a genetic engineering approach, and in addition, the catalytic properties of the enzyme can be improved, using a protein engineering approach, by altering the gene encoding the enzyme.
- the gene encoding an alkaline liquefying ⁇ -amylase has not yet been obtained.
- an object of the present invention is to provide the gene encoding alkaline liquefying ⁇ -amylase and fragments thereof, a transformant harboring recombinant DNA comprising the gene, and a method for producing an alkaline liquefying ⁇ -amylase using the transformant.
- an additional object of the present invention is to provide a means of screening for and isolating additional alkaline liquefying ⁇ -amylase enzymes.
- the present inventors attempted to isolate, from the chromosomal DNA of an alkalophilic Bacillus strain, a DNA fragment containing the gene encoding an alkaline liquefying ⁇ -amylase, and as a result, they were successful in isolating an approximately 1.8 kb DNA fragment encoding an alkaline liquefying ⁇ -amylase.
- they transformed a host microorganism using this DNA fragment ligated to a suitable vector it was confirmed that the resultant recombinant microorganism produced an alkaline liquefying ⁇ -amylase.
- the amino acid sequence of the alkaline liquefying ⁇ -amylase to be encoded is different from that of previously known amylases. The present invention was accomplished based on this finding.
- the present invention provides a DNA fragment encoding an alkaline liquefying ⁇ -amylase.
- the present invention also provides a recombinant DNA comprising the above-described DNA fragment encoding an alkaline liquefying ⁇ -amylase.
- the present invention also provides a transformed microorganism harboring the above-described recombinant DNA comprising a DNA fragment encoding an alkaline liquefying ⁇ -amylase.
- the present invention further provides a method for producing an alkaline liquefying ⁇ -amylase, by culturing the above-described transformed microorganism and collecting the enzyme.
- FIG. 1 shows a restriction enzyme map of a fragment of the gene encoding an alkaline liquefying amylase
- FIG. 2 is a chart depicting construction of pAML 1 OO using a fragment of the gene encoding an alkaline liquefying amylase;
- FIG. 3 shows nucleotide sequences of primers used.
- FIG. 4 is a pH profile of an alkaline liquefying ⁇ -amylase produced by Bacillus sp. KSM-AP1378.
- a useful microorganism which serves as an alkaline liquefying ⁇ -amylase gene donor may be, for example, Bacillus sp. KSM-AP1378 (FERM BP-3048, deposited Jul. 24, 1989 in Fermentation Research Institute, Agency of Industrial Science and Technology of 1-3, Higashi 1-chome, Tsukuba-shi, Ibaraki, 305 Japan), which is an alkalophilic Bacillus strain. This strain was isolated from the soil in the vicinity of the city of Tochigi in Tochigi Prefecture, Japan by the present inventors and identified as a strain which produces significant amounts of alkaline liquefying ⁇ -amylase.
- DNA fragments comprising the alkaline liquefying ⁇ -amylase gene are prepared by cleaving the thus-obtained chromosomal DNA using restriction enzymes. Restriction enzymes which may be used are not particularly limited so long as they do not fragment the gene.
- the alkaline liquefying ⁇ -amylase gene may also be obtained by PCR (Mullis, K. B. and Faloona, F. A., Methods Enzymol., 155, 335 (1987); Saiki, R. K. et al., Science, 239, 487 (1988).
- the gene may be obtained through the synthesis of primers having sequences corresponding to those on the upstream side of the 5′-terminus and on the downstream side of the 3′-terminus of the essential region based on the nucleotide sequence described in Sequence No. 1, and subsequently conducting PCR using, the chromosomal DNA of an alkaline liquefying ⁇ -amylase-producing microorganism as a template.
- an intact gene may be obtained by first obtaining a fragment of the alkaline liquefying ⁇ -amylase gene from an alkaline liquefying ⁇ -amylase-producing microorganism using any procedure, followed by PCR which amplifies the upstream and downstream sides of the fragmentary gene.
- Host/vector systems which may be used are not particularly limited, so far as that host bacterial strains express the alkaline liquefying ⁇ -amylase gene of the present invention, that the recombinant DNA molecules can be replicated in the host bacteria, and that the integrated gene can be stably harbored.
- members of the EK system in which the host is E. coli K-12, and members of the BS system in which the host is Bacillus subtilis Marburg may be used.
- Use of the EK system which encompasses many kinds of vectors and which is extensively studied genetically, provides good results and thus is preferred.
- host bacteria include HB101, C600, and JM109 of the EK system, and BD170, MI112, and ISW1214 of the BS system.
- vectors include pBR322 and pUC18 for the EK system, and pUB110 and pHY300PLK for the BS system.
- a recombinant plasmid DNA molecule is created by cleaving a vector with a restriction enzyme followed by ligation with the above-mentioned chromosomal or PCR-amplified DNA fragment.
- the ligation may be achieved, for example, through the use of a DNA ligase.
- Methods for transforming host bacterial strains using a recombinant DNA molecule are not particularly limited.
- a calcium chloride method (Mandel, M. and Higa, A., J. Mol. Biol., 53, 159 (1970)) may be used in the case of hosts of the EK system
- a protoplast method (Chang, C. and Cohen, S. N., Mol. Gen. Genet., 168, 111 (1978)) may be used in the case of hosts of the BS system.
- Selection of recombinant microorganisms are performed as follows.
- microorganisms which have been transformed with DNA which contains a vector-derived DNA fragment are selected, using as an index a character which is not inactivated by insertion of exogenous chromosomal DNA fragments, such as resistance to antibiotics coded onto the vector DNA.
- exogenous chromosomal DNA fragments such as resistance to antibiotics coded onto the vector DNA.
- pBR322 of the EK system is used as a vector
- a HindIII fragment of chromosomal DNA is inserted into the HindIII cleavage site of pBR322
- the tetracycline resistant gene is inactivated, so a primary selection may be conducted by growth of the transformants that confer ampicillin resistance without having a HindIII cleavage site in the ampicillin gene.
- the selected transformants are transferred onto agar plates containing starch, using, for example, a replica method, and are then cultured so as to form colonies.
- a replica method By staining the starch contained in the starch-containing agar plates using an iodine-containing solution, target recombinant microorganisms can be selected as they decompose starch around the colonies.
- the recombinant DNA molecule harbored by the thus-obtained recombinant microorganism can be extracted using standard procedures for preparing plasmids or phage DNAs (Maniatis, T. et al., Molecular Cloning, Cold Spring Harbor Laboratory, New York (1982)).
- cleavage patterns obtained through the use of various restriction enzymes are analyzed by electrophoresis, it is confirmed that the recombinant DNA molecule is a ligated product of the vector DNA molecule and a DNA fragment containing the alkaline liquefying ⁇ -amylase gene.
- the gene encoding an alkaline liquefying ⁇ -amylase is contained in a DNA fragment of about 2.1 kb shown in the restriction enzyme map of FIG. 1 , and is present in the segment of about 1.6 kb shown by the white bar.
- the gene has a nucleotide sequence shown as Sequence No.1.
- Sequence 1 the 5′ terminus and 3′ terminus correspond to the left-hand side and the right-hand side, respectively, of the fragment of about 2.1 kb shown as Sequence 1.
- an open reading frame (ORF) starting at the 145th nucleotide, ATG, and coding for a sequence consisting of 516 amino acid residues described in Sequence No. 2.
- ⁇ A -type promoter sequence is found at nucleotides from 95 to 125.
- the amino acid sequence of the 10 amino acid residues on the amino terminus side in an alkaline liquefying ⁇ -amylase purified from a culture of Bacillus sp. KSM-AP1378 coincides with the sequence extending from the 37th amino acid (amino acid Nos. 37-46 in Sequence No. 2) deduced from the nucleotide sequence of the present DNA fragment.
- the present gene includes a novel nucleotide sequenced, with the deduced amino acid sequence encoded by the gene being different from those of other ⁇ -amylases such as a liquefying ⁇ -amylase produced by Bacillus amylolique (Takkinen, K. et al., J. Biol. Chem., 258, 1007 (1983)), a liquefying ⁇ -amylase produced by Bacillus stearothermophilus (Nakajima, R. et al., J.
- An example of a preferred recombinant DNA molecule containing the entire region of the alkaline liquefying ⁇ -amylase gene is plasmid pAML100 ( FIG. 2 ).
- This recombinant plasmid has a size of 4.4 kb and formed of a fragment containing a 1.8 kb fragment which contains the alkaline liquefying ⁇ -amylase gene and pUC19.
- An example of a preferred recombinant microorganism harboring the recombinant DNA molecule is an E. coli HB101 (pAML100) strain. This strain was obtained by transforming E. coli HB101 strain with the recombinant plasmid pAML100 using a standard transformation method.
- this strain When this strain is cultured using a medium routinely employed for culturing E. coli, it produces an alkaline liquefying ⁇ -amylase.
- the optimum reaction pH of the thus-produced enzyme is pH 8-9. This agrees well with the activity-pH relationship profile determined for the alkaline liquefying ⁇ -amylase produced by the gene donor bacterial strain, Bacillus sp. KSM-AP1378 ( FIG. 4 ).
- the DNA fragments of the present invention are not necessarily limited only to those encoding the amino acid sequences shown in the below-described sequence listing, so far as they encode a protein exhibiting the enzymatic activity of interest, and they encompass DNA fragments encoding an amino acid sequence in which one or more amino acids are substituted, added, deleted, inverted, or inserted.
- An example of such DNA is one encoding an amino acid sequence equivalent to the amino acid sequence described in Sequence No. 2 from which up to 32 amino acids on the N-terminal side have been deleted.
- a transformed microorganism harboring the aforementioned DNA fragment of the present invention is subjected to culturing.
- the DNA fragment may be integrated in a variety of expression vectors to obtain transformed microorganisms- with enhanced expression ability, followed by culturing of the resultant transformants.
- the transformed microorganisms may be cultured under different conditions depending on the identity of the microorganisms. Thus, culture conditions suited for the host may be used.
- a routine method such as the method described in W 0 94/26881 may be used.
- the DNA fragments of the present invention may be further used as probes for the isolation of homologous alkaline liquefying ⁇ -amylase genes from other organisms.
- Bacillus sp. KSM-AP1378 producing an alkaline liquefying ⁇ -amylase was inoculated in 5 ml of medium A (Table 1) and subjected to shaking culture at 30° C. for 24 hours.
- One ml of the culture was inoculated in 100 ml of the same medium, followed by shaking culture at 30° C. for a further 12 hours.
- cells were collected by centrifugation and about 1 mg of chromosomal DNA was obtained in accordance with a method proposed by Saito and Miura (Saito, H. and Miura K., Biochim Biophys. Acta, 72, 619 (1963)).
- Soluble starch 1.0% Polypepton 1.0% Yeast extract 0.5% KH 2 PO 4 0.1% Na 2 HPO 4 •12H 2 O 0.25% MgSO 4 •7H 2 O 0.02% CaCl 2 •2H 2 O 0.02% FeSO 4 •7H 2 O 0.001% MnCl 2 •4H 2 O 0.0001% Na 2 CO 3 1.0% (separately sterilized)
- primers 1 and 2 ( FIGS. 1 and 3 ) corresponding to regions II and IV were synthesized based on the amino acid sequence of region II and the amino acid sequence of region IV, which are particularly conserved regions among regions I through IV of known alkaline liquefying ⁇ -amylases.
- fragment A chromosomal DNA of XbaI-digested KSM-AP1378 was subjected to Southern hybridization. As a result, it was confirmed that there was a band which hybridized at the location of approximately 1.0 kb.
- An amplified fragment of approximately 0.7 kb (fragment B) was obtained by an inverse PCR method (Triglia, T.
- a primer was designed and synthesized based on the N-terminal amino acid sequence (7 amino acids) of alkaline liquefying ⁇ -amylase from the KSM-AP1378 strain ( FIG. 3 ).
- primer 5 the resultant primer
- primer 3 the primer 3
- chromosomal DNA of KSM-AP1378 PCR was conducted to obtain a fragment of approximately 0.7 kb (fragment C, FIG. 1 ), thereby determining its nucleotide sequence.
- primers 6 and 7 FIGS. 1 and 3
- DNAs which had been obtained by intramolecularly ligating HindIII-digested KSM-AP1378 chromosomal DNA FIG. 1
- an inverse PCR method was performed, obtaining a 1.2 kb fragment in which an upstream 0.8 kb fragment (fragment D) and a downstream PstI-HindIII 0.4 kb fragment had been ligated at the HindIII site.
- the nucleotide sequence of the fragment D region was determined, which revealed the presence of a signal sequence composed of 31 amino acids, MKLHNRIISVLLTLLLAVAVLFPYMTEPAQA (from No. 1 to No. 31 of Sequence No. 2), a deduced SD sequence composed of AAGGAG (nucleotides 127-132; McLaughlin, J. R. et al., J. Biol. Chem., 260, 7178 (1985)), and two kinds of deduced promoter sequences ( ⁇ 35 sequences, TTGAAA; ⁇ 10 sequence, TATGGT, and ⁇ 35 sequence, TTGACT; ⁇ 10 sequence, TAAATT).
- primer A located at approximately 0.1 kb upstream of the promoter sequence
- primer B located 79 b downstream of the termination codon
- chromosomal DNA of KSM-AP1378 as templates
- a stretch of approximately 1.8 kb between the primers was amplified by PCR.
- the resultant amplified fragment was inserted into the SmaI site of pUC19, and then introduced into E. coli HB101.
- the transformant was allowed to grow on an LB agar medium containing 0.4% Starch azure and 15 ⁇ g/ml ampicillin. Colonies which had formed transparent halos around them were isolated as an E. coli strain that produced liquefying ⁇ -amylase.
- a recombinant plasmid was prepared from this transformant, and a restriction enzyme map of the plasmid was made. In the map, it was confirmed that an approximately 1.8 kb DNA fragment (fragment E) shown in FIG. 1 was contained. This recombinant plasmid was designated plasmid pAML100 ( FIG. 2 ).
- the recombinant E. coli obtained in Example 6 was subjected to shaking culture for 12 hours in 5 ml of an LB liquid medium containing 50 ⁇ g/ml of ampicillin.
- One (1) ml of the culture was inoculated to 100 ml of an LB medium (containing ampicillin), followed by shaking-culture at 37° C. for 24 hours.
- Cells collected by centrifugal separation were suspended in Tris-HCl buffer (pH 8.0), and were disrupted by sonication. After the cells were sonicated, cell debris was removed by centrifugal separation, and the resultant supernatant was used as a cell-free extract.
- the cell-free extract of HB101 (PUC19) strain was separately prepared in a similar manner.
- ⁇ -amylase activities in these extracts were measured by first causing a reaction, at 50° C. for 15 minutes, in a reaction mixture containing 50 mM glycine-NaCl-NaOH buffer (pH 10) and soluble starch, and then by quantitatively determining the produced reducing sugar by the 3,5-dinitrosalicylic acid method (WO94/26881).
- One unit of enzymatic activity was defined as the amount of protein that produced a quantity per minute of reducing sugar equivalent to 1 ⁇ mol of glucose.
- ⁇ -amylase activity was detected in the cell-free extract of strain HB101 (pAML100 ). The optimum working pH of ⁇ -amylase was found to fall within the pH range between 8 and 9.
- pH 3.5-5.5 Acetate buffer pH 5.5-8.5: Tris-maleic acid buffer pH 8.5-10.5: Glycine-NaCl—NaOH buffer pH 10.5-11.0: Na 2 CO 3 —NaHCO 3 buffer
- the present invention it is possible to obtain a gene encoding for alkaline liquefying ⁇ -amylase exhibiting the maximum activity in the alkaline pH range as well as a microorganism harboring such gene. Use of them facilitates mass production of alkaline liquefying- ⁇ -amylase.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention provides a DNA fragment encoding alkaline liquefying α-amylase, recombinant DNA containing the DNA fragment, a transformed microorganism harboring the recombinant DNA, as well as a method for producing alkaline liquefying α-amylase using the transformant. The method of the present invention enables mass production of alkaline liquefying α-amylase useful as a detergent component.
The present invention is directed to a liquefying alkaline alphα-amylase, and a DNA encoding for the same and functional fragments thereof.
Description
- The present invention relates to the gene encoding alkaline liquefying α-amylase and fragments thereof, and to recombinant DNA and a transformant bearing the gene or fragments of the gene.
- Alphα-amylase has long been used in a variety of fields. For example, it has been used for the saccharification of grains and potatoes in the fermentation industry, as starch paste removers in the textile industry, as digestives in the pharmaceutical industry, and for the manufacture of thick malt syrups in the food industry. Alphα-amylase is an enzyme which acts on a starch-related polysaccharides such as amylose and amylopectin, hydrolyzing solely the α-1,4-glucoside bond of the polysaccharide molecule. Since 1833, when Payen and Persoz first discovered the enzyme, crystalline samples or electrophoretically homogeneous samples of α-amylase have been obtained from a number of different sources including bacteria, fungi, plant seeds, and animal digestive glands.
- The present inventors have recently discovered that the efficacy of dish-washing detergents and laundry detergents for clothes can be greatly improved, particularly on starch dirts, when α-amylase and a debranching enzyme are both incorporated into these detergents (Japanese Patent Application Laid-open (kokai) No. 2-132192). However, most of the α-amylases previously found in the natural world exhibit maximal and stable enzymatic activities in the neutral to acidic pH ranges, but scarcely work in an alkaline solution of pH 9-10. There exist only a small number of amylase enzymes that are known to exhibit maximal activities in the alkaline pH range (so-called alkaline α-amylases and alkali-resistant α-amylases). These alkaline α-amylases and alkali-resistant α-amylase include, an enzyme produced by Bacillus sp. A-40-2 [Horikoshi, K. et al., Agric. Biol. Chem., 35, 1783 (1971)], an enzyme produced by Bacillus sp. NRRL B-3881 [Boyer, E., J. Bacteriol., 110, 992 (1972)], an enzyme produced by Streptomyces sp. KSM-9 (Japanese Patent Application Laid-Open (kokai) No. 61-209528, an enzyme produced by Bacillus sp. H-167 (Japanese Patent Application Laid-Open (kokai) No. 62-208278, an enzyme produced by Bacillus alkalothermophilus A3-8 (Japanese Patent Application Laid-Open (kokai) No. 2-49584, and an enzyme produced by Natronococcus sp. Ah-36 (Japanese Patent Application Laid-Open (kokai) No. 4-211369.
- As used herein, the term “alkaline 60 -amylase” refers to α-amylases whose optimum pHs fall within the alkaline pH range, whereas the term “alkali-resistant α-amylase” refers to α-amylases which have optimum pHs within the neutral to acidic range but whose activities in the alkaline range are comparable with those obtained at an optimum pH, and in addition, which retain their stabilities in the alkaline range. By the term “neutral range” is meant the range of pH not less than 6 and less than 8, and the term “alkaline” denotes a pH which is higher than the “neutral range”.
- Most of these alkaline α-amylases and alkali-resistant amylases are so-called saccharifying α-amylases which decompose starch or starch-related polysaccharides to glucose, maltose, or maltotriose. As such, these enzymes cause problems if they are used as enzymes for detergents, though they are advantageously used in the manufacture of sugar. Thus, there remains a need for so-called alkaline liquefying α-amylases which exhibit resistance against surfactants used in detergents, and which decompose starch or starch-related polysaccharides in a highly random manner. The present inventors continued an extensive search for microorganisms producing an alkaline liquefying α-amylase suitable as a detergent component, and they discovered that an alkalophilic Bacillus sp. KSM-AP1378 strain, having its optimum pH for growth in the alkaline range, produces an enzyme exhibiting the activity of an alkaline liquefying α-amylase. They elucidated that this enzyme is useful as an additive in detergent compositions for washing dishes and kitchen utensils and for detergent compositions for clothes (W094/26881).
- Amounts of the enzyme produced may be effectively increased by improving a method for culturing an alkaline liquefying α-amylase-producing microorganism, Bacillus sp. KSM-AP1378, or by exploiting mutation. However, in order to produce the enzyme advantageously on an industrial scale, another approach must be taken.
- Amounts of an enzyme produced can be enhanced using a genetic engineering approach, and in addition, the catalytic properties of the enzyme can be improved, using a protein engineering approach, by altering the gene encoding the enzyme. However, the gene encoding an alkaline liquefying α-amylase has not yet been obtained.
- Accordingly, an object of the present invention is to provide the gene encoding alkaline liquefying α-amylase and fragments thereof, a transformant harboring recombinant DNA comprising the gene, and a method for producing an alkaline liquefying α-amylase using the transformant.
- The DNA encoding the alkaline liquefying α-amylase gene may be further used to produce probes to be used in the isolation of additional, homologous alkaline liquefying α-amylase genes from other microorganisms. Thus, an additional object of the present invention is to provide a means of screening for and isolating additional alkaline liquefying α-amylase enzymes. Disclosure of the Invention The present inventors attempted to isolate, from the chromosomal DNA of an alkalophilic Bacillus strain, a DNA fragment containing the gene encoding an alkaline liquefying α-amylase, and as a result, they were successful in isolating an approximately 1.8 kb DNA fragment encoding an alkaline liquefying α-amylase. When they transformed a host microorganism using this DNA fragment ligated to a suitable vector, it was confirmed that the resultant recombinant microorganism produced an alkaline liquefying α-amylase. Moreover, it was found that the amino acid sequence of the alkaline liquefying α-amylase to be encoded is different from that of previously known amylases. The present invention was accomplished based on this finding.
- Accordingly, the present invention provides a DNA fragment encoding an alkaline liquefying α-amylase.
- The present invention also provides a recombinant DNA comprising the above-described DNA fragment encoding an alkaline liquefying α-amylase.
- The present invention also provides a transformed microorganism harboring the above-described recombinant DNA comprising a DNA fragment encoding an alkaline liquefying α-amylase.
- The present invention further provides a method for producing an alkaline liquefying α-amylase, by culturing the above-described transformed microorganism and collecting the enzyme.
-
FIG. 1 shows a restriction enzyme map of a fragment of the gene encoding an alkaline liquefying amylase; -
FIG. 2 is a chart depicting construction of pAML1OO using a fragment of the gene encoding an alkaline liquefying amylase;FIG. 3 shows nucleotide sequences of primers used. -
FIG. 4 is a pH profile of an alkaline liquefying α-amylase produced by Bacillus sp. KSM-AP1378. - In the present invention, a useful microorganism which serves as an alkaline liquefying α-amylase gene donor may be, for example, Bacillus sp. KSM-AP1378 (FERM BP-3048, deposited Jul. 24, 1989 in Fermentation Research Institute, Agency of Industrial Science and Technology of 1-3, Higashi 1-chome, Tsukuba-shi, Ibaraki, 305 Japan), which is an alkalophilic Bacillus strain. This strain was isolated from the soil in the vicinity of the city of Tochigi in Tochigi Prefecture, Japan by the present inventors and identified as a strain which produces significant amounts of alkaline liquefying α-amylase. This strain was deposited at the Fermentation Research Institute, Agency of Industrial Science and Technology (1-3, Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, 305, Japan) under FERM BP-3048 on Aug. 8, 1990 (originally deposited as P-10886 on Jul. 24, 1989).
- In order to obtain chromosomal DNA from a donor microorganism, the method proposed by Marmur, J. (J. Mol. Biol., 3, 208 (1961)) or the method proposed by Saito, H. and Miura, K. (Biochem. Biophys. Acta, 72, 619 (1963)) may be used. Other similar methods may also be used.
- DNA fragments comprising the alkaline liquefying α-amylase gene are prepared by cleaving the thus-obtained chromosomal DNA using restriction enzymes. Restriction enzymes which may be used are not particularly limited so long as they do not fragment the gene. The alkaline liquefying α-amylase gene may also be obtained by PCR (Mullis, K. B. and Faloona, F. A., Methods Enzymol., 155, 335 (1987); Saiki, R. K. et al., Science, 239, 487 (1988). For example, the gene may be obtained through the synthesis of primers having sequences corresponding to those on the upstream side of the 5′-terminus and on the downstream side of the 3′-terminus of the essential region based on the nucleotide sequence described in Sequence No. 1, and subsequently conducting PCR using, the chromosomal DNA of an alkaline liquefying α-amylase-producing microorganism as a template. Alternatively, an intact gene may be obtained by first obtaining a fragment of the alkaline liquefying α-amylase gene from an alkaline liquefying α-amylase-producing microorganism using any procedure, followed by PCR which amplifies the upstream and downstream sides of the fragmentary gene.
- The thus-prepared genetic fragment is then subjected to cloning. Host/vector systems which may be used are not particularly limited, so far as that host bacterial strains express the alkaline liquefying α-amylase gene of the present invention, that the recombinant DNA molecules can be replicated in the host bacteria, and that the integrated gene can be stably harbored. For example, members of the EK system in which the host is E. coli K-12, and members of the BS system in which the host is Bacillus subtilis Marburg, may be used. Use of the EK system, which encompasses many kinds of vectors and which is extensively studied genetically, provides good results and thus is preferred. Specific examples of host bacteria include HB101, C600, and JM109 of the EK system, and BD170, MI112, and ISW1214 of the BS system. Specific examples of vectors include pBR322 and pUC18 for the EK system, and pUB110 and pHY300PLK for the BS system.
- A recombinant plasmid DNA molecule is created by cleaving a vector with a restriction enzyme followed by ligation with the above-mentioned chromosomal or PCR-amplified DNA fragment. The ligation may be achieved, for example, through the use of a DNA ligase.
- Methods for transforming host bacterial strains using a recombinant DNA molecule are not particularly limited. For example, a calcium chloride method (Mandel, M. and Higa, A., J. Mol. Biol., 53, 159 (1970)) may be used in the case of hosts of the EK system, and a protoplast method (Chang, C. and Cohen, S. N., Mol. Gen. Genet., 168, 111 (1978)) may be used in the case of hosts of the BS system. Selection of recombinant microorganisms are performed as follows. First, microorganisms which have been transformed with DNA which contains a vector-derived DNA fragment are selected, using as an index a character which is not inactivated by insertion of exogenous chromosomal DNA fragments, such as resistance to antibiotics coded onto the vector DNA. For example, in a specific case in which pBR322 of the EK system is used as a vector, and a HindIII fragment of chromosomal DNA is inserted into the HindIII cleavage site of pBR322, the tetracycline resistant gene is inactivated, so a primary selection may be conducted by growth of the transformants that confer ampicillin resistance without having a HindIII cleavage site in the ampicillin gene. Subsequently, the selected transformants are transferred onto agar plates containing starch, using, for example, a replica method, and are then cultured so as to form colonies. By staining the starch contained in the starch-containing agar plates using an iodine-containing solution, target recombinant microorganisms can be selected as they decompose starch around the colonies.
- The recombinant DNA molecule harbored by the thus-obtained recombinant microorganism can be extracted using standard procedures for preparing plasmids or phage DNAs (Maniatis, T. et al., Molecular Cloning, Cold Spring Harbor Laboratory, New York (1982)). When cleavage patterns obtained through the use of various restriction enzymes are analyzed by electrophoresis, it is confirmed that the recombinant DNA molecule is a ligated product of the vector DNA molecule and a DNA fragment containing the alkaline liquefying α-amylase gene.
- The gene encoding an alkaline liquefying α-amylase is contained in a DNA fragment of about 2.1 kb shown in the restriction enzyme map of
FIG. 1 , and is present in the segment of about 1.6 kb shown by the white bar. The gene has a nucleotide sequence shown as Sequence No.1. In this sequence, the 5′ terminus and 3′ terminus correspond to the left-hand side and the right-hand side, respectively, of the fragment of about 2.1 kb shown asSequence 1. In this sequence is observed an open reading frame (ORF) starting at the 145th nucleotide, ATG, and coding for a sequence consisting of 516 amino acid residues described in Sequence No. 2. Thirteen bases (13 b) upstream of the ORF, there exists a sequence AAGGAG which is highly complementary to the 3′ terminal sequence of the 16S ribosomal RNA of Bacillus subtilis (McLaughlin, J. R. et al., J. Biol. Chem., 256, 11283 (1981)). On a further upstream region extending nucleotides from 9 to 36, there exists a sequence TTGAAA . . . 16b . . . TATGGT which has high homology with the consensus sequence of a σA-type promoter (Gitt, M. A. et al, J. Biol. Chem., 260, 7178 (1985)). Similarly, another σA-type promoter sequence is found at nucleotides from 95 to 125. The amino acid sequence of the 10 amino acid residues on the amino terminus side in an alkaline liquefying α-amylase purified from a culture of Bacillus sp. KSM-AP1378 coincides with the sequence extending from the 37th amino acid (amino acid Nos. 37-46 in Sequence No. 2) deduced from the nucleotide sequence of the present DNA fragment. - When the nucleotide sequence of the gene of the present invention and a deduced amino acid sequence were compared with those of α-amylase known hitherto, it was confirmed that the present gene includes a novel nucleotide sequenced, with the deduced amino acid sequence encoded by the gene being different from those of other α-amylases such as a liquefying α-amylase produced by Bacillus amylolique (Takkinen, K. et al., J. Biol. Chem., 258, 1007 (1983)), a liquefying α-amylase produced by Bacillus stearothermophilus (Nakajima, R. et al., J. Bacteriol., 163, 401 (1985)), a liquefying α-amylase produced by Bacillus licheniformis (Yuuki, T et al., J. Biochem., 98, 1147 (1985)), or a liquefying α-amylase produced by Bacillus sp. 707 (Tsukamoto, A. et al., Biochem. Biophys. Res. Commun., 151, 25 (1988)).
- An example of a preferred recombinant DNA molecule containing the entire region of the alkaline liquefying α-amylase gene is plasmid pAML100 (
FIG. 2 ). This recombinant plasmid has a size of 4.4 kb and formed of a fragment containing a 1.8 kb fragment which contains the alkaline liquefying α-amylase gene and pUC19. An example of a preferred recombinant microorganism harboring the recombinant DNA molecule is an E. coli HB101 (pAML100) strain. This strain was obtained by transforming E. coli HB101 strain with the recombinant plasmid pAML100 using a standard transformation method. When this strain is cultured using a medium routinely employed for culturing E. coli, it produces an alkaline liquefying α-amylase. The optimum reaction pH of the thus-produced enzyme is pH 8-9. This agrees well with the activity-pH relationship profile determined for the alkaline liquefying α-amylase produced by the gene donor bacterial strain, Bacillus sp. KSM-AP1378 (FIG. 4 ). - The DNA fragments of the present invention are not necessarily limited only to those encoding the amino acid sequences shown in the below-described sequence listing, so far as they encode a protein exhibiting the enzymatic activity of interest, and they encompass DNA fragments encoding an amino acid sequence in which one or more amino acids are substituted, added, deleted, inverted, or inserted. An example of such DNA is one encoding an amino acid sequence equivalent to the amino acid sequence described in Sequence No. 2 from which up to 32 amino acids on the N-terminal side have been deleted.
- In order to produce an alkaline liquefying α-amylase using the transformed microorganism of the present invention, a transformed microorganism harboring the aforementioned DNA fragment of the present invention is subjected to culturing. Alternatively, the DNA fragment may be integrated in a variety of expression vectors to obtain transformed microorganisms- with enhanced expression ability, followed by culturing of the resultant transformants. Moreover, the transformed microorganisms may be cultured under different conditions depending on the identity of the microorganisms. Thus, culture conditions suited for the host may be used. In order to collect an alkaline liquefying α-amylase from the resultant culture, a routine method (such as the method described in W094/26881) may be used.
- The DNA fragments of the present invention may be further used as probes for the isolation of homologous alkaline liquefying α-amylase genes from other organisms.
- The present invention will next be described in more detail by way of examples, which should not be construed as limiting the invention thereto. Concentrations in the Examples are all on a basis of % by weight.
- Bacillus sp. KSM-AP1378 producing an alkaline liquefying α-amylase was inoculated in 5 ml of medium A (Table 1) and subjected to shaking culture at 30° C. for 24 hours. One ml of the culture was inoculated in 100 ml of the same medium, followed by shaking culture at 30° C. for a further 12 hours. Subsequently, cells were collected by centrifugation and about 1 mg of chromosomal DNA was obtained in accordance with a method proposed by Saito and Miura (Saito, H. and Miura K., Biochim Biophys. Acta, 72, 619 (1963)).
-
TABLE 1 Composition of medium A Soluble starch 1.0% Polypepton 1.0% Yeast extract 0.5% KH2PO4 0.1% Na2HPO4•12H2O 0.25% MgSO4•7H2O 0.02% CaCl2•2H2O 0.02% FeSO4•7H2O 0.001% MnCl2•4H2O 0.0001% Na2CO3 1.0% (separately sterilized) - It is known that many members of the amylase family possess I-IV regions where amino acid sequences are conserved at a high level (Nakajima, R. et al., Appl. Microbiol. Biotechnol., 23, 355 (1986)). Therefore,
primers 1 and 2 (FIGS. 1 and 3 ) corresponding to regions II and IV were synthesized based on the amino acid sequence of region II and the amino acid sequence of region IV, which are particularly conserved regions among regions I through IV of known alkaline liquefying α-amylases. Using the thus-synthesized primers and chromosomal DNA of KSM-AP1378 (which served as template), PCR was conducted (one cycle=94° C.×1 min.+42° C.×1 min.+60° C.×2 min., 30 cycles). A gene fragment of approximately 0.3 kb (fragment A) shown inFIG. 1 was obtained, and the nucleotide sequence of this fragment was determined. As a result, it was found that the present fragment was coded with an amino acid sequence exhibiting a non-negligible level of homology with the amino acid sequence extending from region II through region IV of known liquefying amylase. - Using fragment A as a probe, chromosomal DNA of XbaI-digested KSM-AP1378 was subjected to Southern hybridization. As a result, it was confirmed that there was a band which hybridized at the location of approximately 1.0 kb. An amplified fragment of approximately 0.7 kb (fragment B) was obtained by an inverse PCR method (Triglia, T. et al., Nucleic Acids Res., 16, 81 (1988)) using primers synthesized from the terminal sequences of fragment A (on the side of region II:
primer 3; on the side of region IV: primer 4) and DNAs which had been obtained by intramolecularly ligating XbaI-digested KSM-AP1378 chromosomal DNA (FIG. 1 ) as template. The nucleotide sequence of fragment B was determined, which revealed that the present fragment contained a stretch, approximately 0.6 kb region downstream from region IV. The present fragment contained a termination codon for the ORF, which was deduced to be attributed to alkaline liquefying α-amylase. - A primer was designed and synthesized based on the N-terminal amino acid sequence (7 amino acids) of alkaline liquefying α-amylase from the KSM-AP1378 strain (
FIG. 3 ). Using the resultant primer (primer 5) in combination with the aforementioned primer 3 (FIG. 3 ) and, as a template, chromosomal DNA of KSM-AP1378, PCR was conducted to obtain a fragment of approximately 0.7 kb (fragment C,FIG. 1 ), thereby determining its nucleotide sequence. - A primer containing 21 bases, stretching directly downstream of the nucleotide sequence encoding N-terminal amino acid sequence of the purified enzyme, was synthesized (primer 6). Using
primers 6 and 7 (FIGS. 1 and 3 ) and DNAs which had been obtained by intramolecularly ligating HindIII-digested KSM-AP1378 chromosomal DNA (FIG. 1 ) as templates, an inverse PCR method was performed, obtaining a 1.2 kb fragment in which an upstream 0.8 kb fragment (fragment D) and a downstream PstI-HindIII 0.4 kb fragment had been ligated at the HindIII site. The nucleotide sequence of the fragment D region was determined, which revealed the presence of a signal sequence composed of 31 amino acids, MKLHNRIISVLLTLLLAVAVLFPYMTEPAQA (from No. 1 to No. 31 of Sequence No. 2), a deduced SD sequence composed of AAGGAG (nucleotides 127-132; McLaughlin, J. R. et al., J. Biol. Chem., 260, 7178 (1985)), and two kinds of deduced promoter sequences (−35 sequences, TTGAAA; −10 sequence, TATGGT, and −35 sequence, TTGACT; −10 sequence, TAAATT). - Using primer A located at approximately 0.1 kb upstream of the promoter sequence, primer B located 79 b downstream of the termination codon, and chromosomal DNA of KSM-AP1378 as templates, a stretch of approximately 1.8 kb between the primers was amplified by PCR. The resultant amplified fragment was inserted into the SmaI site of pUC19, and then introduced into E. coli HB101. The transformant was allowed to grow on an LB agar medium containing 0.4% Starch azure and 15 μg/ml ampicillin. Colonies which had formed transparent halos around them were isolated as an E. coli strain that produced liquefying α-amylase. A recombinant plasmid was prepared from this transformant, and a restriction enzyme map of the plasmid was made. In the map, it was confirmed that an approximately 1.8 kb DNA fragment (fragment E) shown in
FIG. 1 was contained. This recombinant plasmid was designated plasmid pAML100 (FIG. 2 ). - The recombinant E. coli obtained in Example 6 was subjected to shaking culture for 12 hours in 5 ml of an LB liquid medium containing 50 μg/ml of ampicillin. One (1) ml of the culture was inoculated to 100 ml of an LB medium (containing ampicillin), followed by shaking-culture at 37° C. for 24 hours. Cells collected by centrifugal separation were suspended in Tris-HCl buffer (pH 8.0), and were disrupted by sonication. After the cells were sonicated, cell debris was removed by centrifugal separation, and the resultant supernatant was used as a cell-free extract. As a control, the cell-free extract of HB101 (PUC19) strain was separately prepared in a similar manner. α-amylase activities in these extracts were measured by first causing a reaction, at 50° C. for 15 minutes, in a reaction mixture containing 50 mM glycine-NaCl-NaOH buffer (pH 10) and soluble starch, and then by quantitatively determining the produced reducing sugar by the 3,5-dinitrosalicylic acid method (WO94/26881). One unit of enzymatic activity was defined as the amount of protein that produced a quantity per minute of reducing sugar equivalent to 1 μmol of glucose. As a result, α-amylase activity was detected in the cell-free extract of strain HB101 (pAML100 ). The optimum working pH of α-amylase was found to fall within the pH range between 8 and 9. This result coincides well with the optimum pH of liquefying α-amylase produced by Bacillus sp. KSM-AP1378 (
FIG. 4 ). For the measurement of enzymatic activities, the buffers shown in Table 2 below were used (each at 40 mM). -
TABLE 2 pH 3.5-5.5: Acetate buffer pH 5.5-8.5: Tris-maleic acid buffer pH 8.5-10.5: Glycine-NaCl—NaOH buffer pH 10.5-11.0: Na2CO3—NaHCO3 buffer - According to the present invention, it is possible to obtain a gene encoding for alkaline liquefying α-amylase exhibiting the maximum activity in the alkaline pH range as well as a microorganism harboring such gene. Use of them facilitates mass production of alkaline liquefying-α-amylase.
Claims (9)
1. An isolated DNA molecule encoding a protein exhibiting alkaline liquefying α-amylase activity at a pH optimum of 8-9 and possessing an amino acid sequence obtained by modifying an amino acid sequence described in SEQ ID NO: 2 in a manner in which one or more amino acids are substituted, deleted, or inserted without changing the enzymological properties of the protein having said amino acid sequence described in SEQ ID NO:2 and the protein hydrolyzes 1,4-α-glucosidic linkages in starches, amylose, amylopectin, and degradation products thereof and in amylose forms: glucose (G1), maltose (G2), maltotriose (G3), maltotetrose (G4), maltopentose (G5) and maltohexose (G6) and does not hydrolyze pullulan.
2. The DNA molecule of claim 1 , further comprising a nucleotide sequence for regulating expression of said isolated DNA molecule.
3. A recombinant DNA molecule comprising the isolated DNA molecule of claim 1 .
4. A recombinant DNA molecule comprising the isolated DNA molecule of claim 2 .
5. The DNA molecule of claim 1 , wherein said encoded protein has an isolectric point higher than 8.5 when measured by isoelectric focusing electrophoresis.
6. The DNA molecule of claim 1 , wherein said encoded protein:
acts in a pH range of 5.0 to 11.0, with an optimum pH in the range of 8.0 to 9.0;
is stable in a pH range of 5.0 to 10.5 and retains at least 50% of activity after treatment at 40° C. for 30 minutes;
acts in a temperature range of 20° C. to 80° C., with an optimum temperature in the range of 45° C. to 55° C.;
is stable at temperatures of 50° C. or lower when treated for 30 minutes in a glycine-salt-sodium hydroxide buffer having pH 8.5;
has a molecular weight of 50,000±5000 when measured by sodium dodecyl sulfate polyacrylamide gel electrophoresis;
has an isoelectric point of approximately 9.2 when measured by isoelectric focusing electrophoresis;
is stable in the presence of K+, Na+, Ca2+, Mg2+, Mn2+, Ba2+, Fe2+, Fe3+, or A1 3+; and
is substantially free of inhibition by surfactants selected from the group consisting of sodium linear alkylbenzene sulfonates, sodium alkylsulfonate esters, sodium polyoxyethylene alkylsulfate esters, sodium alkylsulfonates, soaps and polyoxyethylene alkyl ethers.
7. An isolated DNA molecule encoding a protein exhibiting alkaline liquefying α-amylase activity at a pH optimum of 8-9 comprising at least one nucleotide sequence that is selected from the group consisting of SEQ ID NO: 10, SEQ ID NO: 7, SEQ ID NO: 3, SEQ ID NO: 6 and SEQ ID NO: 9.
8. An isolated DNA molecule encoding a protein exhibiting alkaline liquefying α-amylase activity at a pH optimum of 8-9 comprising at least one nucleotide sequence that is the reverse complement of a sequence selected from the group consisting of SEQ ID NO: 8, SEQ ID NO: 4 and SEQ ID NO: 11.
9. An isolated DNA molecule encoding a protein exhibiting alkaline liquefying α-amylase activity at a pH optimum of 8-9 comprising at least one nucleotide sequence selected from the group consisting of SEQ ID NO: 10, SEQ ID NO: 7, SEQ ID NO: 3, SEQ ID NO: 6 and SEQ ID NO: 9, and also comprising at least one nucleotide sequence that is the reverse complement of a sequence selected from the group consisting of SEQ ID NO: 8, SEQ ID NO: 4 and SEQ ID NO: 11.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/829,331 US20080050807A1 (en) | 1995-06-14 | 2004-04-22 | Gene encoding alkaline liquefying alpha-amylase |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP147257/1995 | 1995-06-14 | ||
JP7147257A JP3025627B2 (en) | 1995-06-14 | 1995-06-14 | Liquefied alkaline α-amylase gene |
US08/952,741 US6979731B1 (en) | 1995-06-14 | 1996-06-14 | Gene encoding alkaline liquefying α-amylase |
JPPCT/JP96/01647 | 1996-06-14 | ||
US10/829,331 US20080050807A1 (en) | 1995-06-14 | 2004-04-22 | Gene encoding alkaline liquefying alpha-amylase |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/952,741 Continuation US6979731B1 (en) | 1995-06-14 | 1996-06-14 | Gene encoding alkaline liquefying α-amylase |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080050807A1 true US20080050807A1 (en) | 2008-02-28 |
Family
ID=15426147
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/952,741 Expired - Fee Related US6979731B1 (en) | 1995-06-14 | 1996-06-14 | Gene encoding alkaline liquefying α-amylase |
US09/986,676 Expired - Fee Related US6638748B2 (en) | 1995-06-14 | 2001-11-09 | Gene encoding alkaline liquifying alpha-amylase |
US10/829,331 Abandoned US20080050807A1 (en) | 1995-06-14 | 2004-04-22 | Gene encoding alkaline liquefying alpha-amylase |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/952,741 Expired - Fee Related US6979731B1 (en) | 1995-06-14 | 1996-06-14 | Gene encoding alkaline liquefying α-amylase |
US09/986,676 Expired - Fee Related US6638748B2 (en) | 1995-06-14 | 2001-11-09 | Gene encoding alkaline liquifying alpha-amylase |
Country Status (7)
Country | Link |
---|---|
US (3) | US6979731B1 (en) |
EP (1) | EP0833927B1 (en) |
JP (1) | JP3025627B2 (en) |
CN (1) | CN1128221C (en) |
DE (1) | DE69636475T2 (en) |
DK (1) | DK0833927T3 (en) |
WO (1) | WO1997000324A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011005932A1 (en) | 2009-07-10 | 2011-01-13 | The Procter & Gamble Company | Compositions containing benefit agent delivery particles |
WO2011005943A1 (en) | 2009-07-10 | 2011-01-13 | The Procter & Gamble Company | Compositions containing benefit agent delivery particles |
Families Citing this family (277)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR000862A1 (en) * | 1995-02-03 | 1997-08-06 | Novozymes As | VARIANTS OF A MOTHER-AMYLASE, A METHOD TO PRODUCE THE SAME, A DNA STRUCTURE AND A VECTOR OF EXPRESSION, A CELL TRANSFORMED BY SUCH A DNA STRUCTURE AND VECTOR, A DETERGENT ADDITIVE, DETERGENT COMPOSITION, A COMPOSITION FOR AND A COMPOSITION FOR THE ELIMINATION OF |
US6486113B1 (en) | 1997-03-31 | 2002-11-26 | Kao Corporation | Mutant α-amylases |
US7078213B1 (en) | 1998-02-18 | 2006-07-18 | Novozymes A/S | Alkaline Bacillus amylase |
US6623948B1 (en) * | 1999-03-31 | 2003-09-23 | Novozymes A/S | Nucleic acid sequences encoding alkaline alpha-amylases |
WO2000060058A2 (en) | 1999-03-31 | 2000-10-12 | Novozymes A/S | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
EP1173554A2 (en) | 1999-03-31 | 2002-01-23 | Novozymes A/S | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
WO2001064852A1 (en) * | 2000-03-03 | 2001-09-07 | Novozymes A/S | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
CN100482790C (en) | 2000-03-08 | 2009-04-29 | 诺维信公司 | Variants with altered properties |
EP1307547B1 (en) | 2000-07-28 | 2005-10-26 | Henkel Kommanditgesellschaft auf Aktien | Novel amylolytic enzyme extracted from bacillus sp. a 7-7 (dsm 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
US20020155574A1 (en) | 2000-08-01 | 2002-10-24 | Novozymes A/S | Alpha-amylase mutants with altered properties |
JP4855632B2 (en) | 2000-08-01 | 2012-01-18 | ノボザイムス アクティーゼルスカブ | Α-Amylase mutants with altered properties |
US20040091994A1 (en) | 2000-10-13 | 2004-05-13 | Carsten Andersen | Alpha-amylase variant with altered properties |
AU2002233186A1 (en) | 2000-11-28 | 2002-06-11 | Henkel Kommanditgesellschaft Auf Aktien | Cyclodextrin glucanotransferase (cgtase), obtained from bacillus agaradherens (dsm 9948) and detergents and cleaning agents containing said novel cyclodextrin glucanotransferase |
AU2002254876A1 (en) | 2001-05-15 | 2002-11-25 | Novozymes A/S | Alpha-amylase variant with altered properties |
DE10163748A1 (en) | 2001-12-21 | 2003-07-17 | Henkel Kgaa | New glycosyl hydrolases |
CN1313608C (en) * | 2004-01-18 | 2007-05-02 | 中国科学院微生物研究所 | Basic alpha-diastase, and its coding gene and production method |
CN107151662B (en) | 2004-07-05 | 2021-06-29 | 诺维信公司 | Alpha-amylase variants with altered properties |
CN103182387B (en) | 2004-09-10 | 2016-01-06 | 诺维信北美公司 | Prevent, remove, reduce or the method for disrupting biofilm |
CA2592083C (en) | 2004-12-22 | 2017-02-21 | Novozymes A/S | Hybrid enzymes consisting of an endo-amylase first amino acid sequence and a carbohydrate-binding module as second amino acid sequence |
DE102006038448A1 (en) | 2005-12-28 | 2008-02-21 | Henkel Kgaa | Enzyme-containing cleaning agent |
WO2007149699A2 (en) | 2006-06-21 | 2007-12-27 | Novozymes North America, Inc. | Desizing and scouring process |
CN101668855B (en) * | 2007-03-23 | 2013-07-03 | 丹尼斯科美国公司 | Enhanced amylase production by n-terminal addition to mature amylase protein |
EP2215202B2 (en) | 2007-11-05 | 2024-01-10 | Danisco US Inc. | VARIANTS OF BACILLUS sp. TS-23 ALPHA-AMYLASE WITH ALTERED PROPERTIES |
AU2008325249B2 (en) | 2007-11-05 | 2013-10-10 | Danisco Us Inc. | Alpha-amylase variants with altered properties |
AU2009212526A1 (en) | 2008-02-04 | 2009-08-13 | Danisco Us Inc. | TS23 alpha-amylase variants with altered properties |
US8066818B2 (en) | 2008-02-08 | 2011-11-29 | The Procter & Gamble Company | Water-soluble pouch |
US20090209447A1 (en) | 2008-02-15 | 2009-08-20 | Michelle Meek | Cleaning compositions |
EP2100947A1 (en) | 2008-03-14 | 2009-09-16 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
AU2009256280B2 (en) | 2008-06-06 | 2013-03-07 | Danisco Us Inc. | Geobacillus stearothermophilus alpha-amylase (AmyS) variants with improved properties |
EP2166092A1 (en) | 2008-09-18 | 2010-03-24 | The Procter and Gamble Company | Detergent composition |
EP2166075A1 (en) * | 2008-09-23 | 2010-03-24 | The Procter and Gamble Company | Cleaning composition |
EP2166073A1 (en) * | 2008-09-23 | 2010-03-24 | The Procter & Gamble Company | Cleaning composition |
EP2166076A1 (en) | 2008-09-23 | 2010-03-24 | The Procter & Gamble Company | Cleaning composition |
CN102224234B (en) | 2008-09-25 | 2014-04-16 | 丹尼斯科美国公司 | Alpha-amylase blends and methods for using said blends |
US20100125046A1 (en) | 2008-11-20 | 2010-05-20 | Denome Frank William | Cleaning products |
EP2216393B1 (en) | 2009-02-09 | 2024-04-24 | The Procter & Gamble Company | Detergent composition |
BR112012000531A2 (en) | 2009-07-09 | 2019-09-24 | Procter & Gamble | catalytic laundry detergent composition comprising relatively low levels of water-soluble electrolyte |
CN102471729A (en) | 2009-07-09 | 2012-05-23 | 宝洁公司 | A catalytic laundry detergent composition comprising relatively low levels of water-soluble electrolyte |
EP2292725B2 (en) | 2009-08-13 | 2022-08-24 | The Procter & Gamble Company | Method of laundering fabrics at low temperature |
CN102652175B (en) | 2009-12-09 | 2016-02-10 | 宝洁公司 | Fabric and household care product |
ES2422593T3 (en) | 2009-12-10 | 2013-09-12 | Procter & Gamble | Method and use of a dishwasher composition |
EP2333039B2 (en) | 2009-12-10 | 2020-11-11 | The Procter & Gamble Company | Method and use of a dishwasher composition |
EP2333042B1 (en) | 2009-12-10 | 2015-07-01 | The Procter and Gamble Company | Automatic dishwashing product and use thereof |
EP2333040B2 (en) | 2009-12-10 | 2019-11-13 | The Procter & Gamble Company | Detergent composition |
US20130071913A1 (en) | 2009-12-22 | 2013-03-21 | Novozymes A/S | Use of amylase variants at low temperature |
CN102918149A (en) | 2010-01-04 | 2013-02-06 | 诺维信公司 | Alpha-amylases |
EP2357220A1 (en) | 2010-02-10 | 2011-08-17 | The Procter & Gamble Company | Cleaning composition comprising amylase variants with high stability in the presence of a chelating agent |
US9896673B2 (en) | 2010-02-10 | 2018-02-20 | Novozymes A/S | Compositions of high stability alpha amylase variants |
ES2401126T3 (en) | 2010-02-25 | 2013-04-17 | The Procter & Gamble Company | Detergent composition |
EP2380963B1 (en) | 2010-04-23 | 2015-12-23 | The Procter and Gamble Company | Method of perfuming |
EP2383329A1 (en) | 2010-04-23 | 2011-11-02 | The Procter & Gamble Company | Particle |
EP2380478A1 (en) | 2010-04-23 | 2011-10-26 | The Procter & Gamble Company | Automatic dishwashing product |
ES2579217T3 (en) | 2010-04-23 | 2016-08-08 | The Procter & Gamble Company | Particle |
TR201810936T4 (en) | 2010-04-23 | 2018-08-27 | Industrial Chemicals Group Ltd | Detergent composition. |
ES2533368T3 (en) | 2010-04-23 | 2015-04-09 | The Procter & Gamble Company | Dishwasher product |
CN105925556B (en) | 2010-05-06 | 2020-11-13 | 丹尼斯科美国公司 | Compositions and methods comprising subtilisin variants |
BR112012028033B1 (en) | 2010-06-22 | 2021-04-27 | Novozymes A/S | METHOD TO UNLEASH SKIN FROM RAW LEATHER OR SKIN, PROCESSES FOR DEPILATION OF RAW LEATHER OR SKIN, AND TO PREPARE A WET BLUE |
EP2420558B1 (en) | 2010-08-17 | 2017-08-02 | The Procter & Gamble Company | Stable sustainable hand dish-washing detergents |
PL2606111T3 (en) | 2010-08-17 | 2018-05-30 | The Procter And Gamble Company | Method for hand washing dishes having long lasting suds |
DK2705146T3 (en) | 2011-05-05 | 2019-03-04 | Danisco Us Inc | COMPOSITIONS AND PROCEDURES INCLUDING SERINE PROTEASE VARIABLES |
JP5933688B2 (en) | 2011-05-05 | 2016-06-15 | ザ プロクター アンド ギャンブル カンパニー | Compositions and methods comprising serine protease variants |
US20140371435A9 (en) | 2011-06-03 | 2014-12-18 | Eduardo Torres | Laundry Care Compositions Containing Thiophene Azo Dyes |
EP2537918A1 (en) | 2011-06-20 | 2012-12-26 | The Procter & Gamble Company | Consumer products with lipase comprising coated particles |
PL3543333T3 (en) * | 2011-06-30 | 2022-06-13 | Novozymes A/S | Method for screening alpha-amylases |
EP3798303A1 (en) | 2011-06-30 | 2021-03-31 | Novozymes A/S | Alpha-amylase-variants |
EP2551335A1 (en) | 2011-07-25 | 2013-01-30 | The Procter & Gamble Company | Enzyme stabilized liquid detergent composition |
ES2633292T3 (en) | 2011-10-19 | 2017-09-20 | The Procter & Gamble Company | Particle |
WO2013116261A2 (en) | 2012-02-03 | 2013-08-08 | The Procter & Gamble Company | Compositions and methods for surface treatment with lipases |
IN2014DN07573A (en) | 2012-03-19 | 2015-04-24 | Procter & Gamble | |
EP2834353B1 (en) | 2012-04-02 | 2017-07-19 | Novozymes A/S | Lipase variants and polynucleotides encoding same |
PL2662436T3 (en) | 2012-05-11 | 2018-02-28 | The Procter And Gamble Company | Detergent composition |
EP2674475A1 (en) | 2012-06-11 | 2013-12-18 | The Procter & Gamble Company | Detergent composition |
US10246692B2 (en) | 2012-07-12 | 2019-04-02 | Novozymes A/S | Polypeptides having lipase activity and polynucleotides encoding same |
EP2700704B1 (en) | 2012-08-24 | 2018-05-09 | The Procter and Gamble Company | Dishwashing method |
ES2677702T3 (en) | 2012-08-24 | 2018-08-06 | The Procter & Gamble Company | Dishwashing method |
WO2014086659A2 (en) | 2012-12-06 | 2014-06-12 | Ahmedabad Textile Industry's Research Association | Method for enzymatical preparation of textiles |
EP2746381A1 (en) | 2012-12-21 | 2014-06-25 | The Procter & Gamble Company | Cleaning pack |
US20140255330A1 (en) | 2013-03-05 | 2014-09-11 | The Procter & Gamble Company | Mixed Sugar Compositions |
WO2014147127A1 (en) | 2013-03-21 | 2014-09-25 | Novozymes A/S | Polypeptides with lipase activity and polynucleotides encoding same |
PL2978830T3 (en) | 2013-03-28 | 2019-08-30 | The Procter & Gamble Company | Cleaning compositions containing a polyetheramine |
AR096478A1 (en) | 2013-05-28 | 2016-01-13 | Procter & Gamble | COMPOSITIONS FOR SURFACE TREATMENT THAT INCLUDE PHOTOCROMÁTIC DYES |
WO2015042209A1 (en) | 2013-09-18 | 2015-03-26 | The Procter & Gamble Company | Laundry care compositions containing thiophene azo carboxylate dyes |
CN105555935A (en) | 2013-09-18 | 2016-05-04 | 宝洁公司 | Laundry care composition comprising carboxylate dye |
CA2921432A1 (en) | 2013-09-18 | 2015-03-26 | The Procter & Gamble Company | Laundry care composition comprising carboxylate dye |
US9834682B2 (en) | 2013-09-18 | 2017-12-05 | Milliken & Company | Laundry care composition comprising carboxylate dye |
EP2857485A1 (en) | 2013-10-07 | 2015-04-08 | WeylChem Switzerland AG | Multi-compartment pouch comprising alkanolamine-free cleaning compositions, washing process and use for washing and cleaning of textiles and dishes |
EP2857487A1 (en) | 2013-10-07 | 2015-04-08 | WeylChem Switzerland AG | Multi-compartment pouch comprising cleaning compositions, washing process and use for washing and cleaning of textiles and dishes |
EP2857486A1 (en) | 2013-10-07 | 2015-04-08 | WeylChem Switzerland AG | Multi-compartment pouch comprising cleaning compositions, washing process and use for washing and cleaning of textiles and dishes |
EP3097172A1 (en) | 2014-01-22 | 2016-11-30 | The Procter & Gamble Company | Method of treating textile fabrics |
WO2015112340A1 (en) | 2014-01-22 | 2015-07-30 | The Procter & Gamble Company | Method of treating textile fabrics |
WO2015112341A1 (en) | 2014-01-22 | 2015-07-30 | The Procter & Gamble Company | Fabric treatment composition |
EP3097173B1 (en) | 2014-01-22 | 2020-12-23 | The Procter and Gamble Company | Fabric treatment composition |
EP3110778B1 (en) | 2014-02-25 | 2025-05-14 | The Procter & Gamble Company | A process for making renewable surfactant intermediates and surfactants from fats and oils and products thereof |
US10752562B2 (en) | 2014-02-25 | 2020-08-25 | The Procter & Gamble Company | Process for making renewable surfactant intermediates and surfactants from fats and oils and products thereof |
MX2016011110A (en) | 2014-02-26 | 2016-12-05 | Procter & Gamble | Anti-foam compositions. |
EP2915872A1 (en) | 2014-03-06 | 2015-09-09 | The Procter and Gamble Company | Dishwashing composition |
EP2915873A1 (en) | 2014-03-06 | 2015-09-09 | The Procter and Gamble Company | Dishwashing composition |
WO2015148361A1 (en) | 2014-03-27 | 2015-10-01 | The Procter & Gamble Company | Cleaning compositions containing a polyetheramine |
CA2941253A1 (en) | 2014-03-27 | 2015-10-01 | Frank Hulskotter | Cleaning compositions containing a polyetheramine |
EP2924105A1 (en) | 2014-03-28 | 2015-09-30 | The Procter and Gamble Company | Water soluble unit dose article |
EP2924106A1 (en) | 2014-03-28 | 2015-09-30 | The Procter and Gamble Company | Water soluble unit dose article |
EP2940116B1 (en) | 2014-04-30 | 2018-10-17 | The Procter and Gamble Company | Detergent |
BR112016025504B1 (en) | 2014-05-06 | 2022-02-15 | Milliken & Company | COMPOSITIONS FOR LAUNDRY CARE AND METHOD FOR TREATMENT TEXTILE ARTICLES |
WO2015187757A1 (en) | 2014-06-06 | 2015-12-10 | The Procter & Gamble Company | Detergent composition comprising polyalkyleneimine polymers |
US9617502B2 (en) | 2014-09-15 | 2017-04-11 | The Procter & Gamble Company | Detergent compositions containing salts of polyetheramines and polymeric acid |
US20160090552A1 (en) | 2014-09-25 | 2016-03-31 | The Procter & Gamble Company | Detergent compositions containing a polyetheramine and an anionic soil release polymer |
US9487739B2 (en) | 2014-09-25 | 2016-11-08 | The Procter & Gamble Company | Cleaning compositions containing a polyetheramine |
US9388368B2 (en) | 2014-09-26 | 2016-07-12 | The Procter & Gamble Company | Cleaning compositions containing a polyetheramine |
AR102683A1 (en) | 2014-11-17 | 2017-03-15 | Procter & Gamble | BENEFIT AGENT SUPPLY COMPOSITIONS |
EP3026103B1 (en) | 2014-11-26 | 2018-07-25 | The Procter and Gamble Company | Cleaning pouch |
PL3026099T3 (en) | 2014-11-26 | 2021-06-14 | The Procter & Gamble Company | Cleaning pouch |
PL3026102T3 (en) | 2014-11-26 | 2019-06-28 | The Procter & Gamble Company | Cleaning pouch |
ES2690335T3 (en) | 2014-11-26 | 2018-11-20 | The Procter & Gamble Company | Cleaning bag |
EP3034596B2 (en) | 2014-12-17 | 2021-11-10 | The Procter & Gamble Company | Detergent composition |
EP3034597A1 (en) | 2014-12-17 | 2016-06-22 | The Procter and Gamble Company | Detergent composition |
ES2733300T3 (en) | 2014-12-17 | 2019-11-28 | Procter & Gamble | Detergent composition |
EP3034592A1 (en) | 2014-12-17 | 2016-06-22 | The Procter and Gamble Company | Method of automatic dishwashing |
EP3034590A1 (en) | 2014-12-17 | 2016-06-22 | The Procter and Gamble Company | Method of automatic dishwashing |
EP3034591A1 (en) | 2014-12-17 | 2016-06-22 | The Procter and Gamble Company | Method of automatic dishwashing |
EP3034589A1 (en) | 2014-12-17 | 2016-06-22 | The Procter and Gamble Company | Detergent composition |
EP3037512B1 (en) | 2014-12-22 | 2018-02-28 | The Procter and Gamble Company | Process for recycling detergent pouches |
EP3050951A1 (en) | 2015-02-02 | 2016-08-03 | The Procter and Gamble Company | Method of dishwashing |
EP3050948B1 (en) | 2015-02-02 | 2018-09-19 | The Procter and Gamble Company | New use of complexing agent |
EP3050952A1 (en) | 2015-02-02 | 2016-08-03 | The Procter and Gamble Company | Method of dishwashing |
EP3050954A1 (en) | 2015-02-02 | 2016-08-03 | The Procter and Gamble Company | New use of sulfonated polymers |
EP3050953B1 (en) | 2015-02-02 | 2018-12-26 | The Procter and Gamble Company | Detergent composition |
EP3050955B2 (en) | 2015-02-02 | 2023-11-08 | The Procter & Gamble Company | Detergent pack |
EP3050950B1 (en) | 2015-02-02 | 2018-09-19 | The Procter and Gamble Company | New use of sulfonated polymers |
EP3050947A1 (en) | 2015-02-02 | 2016-08-03 | The Procter and Gamble Company | Detergent pack |
CN117736810A (en) | 2015-04-29 | 2024-03-22 | 宝洁公司 | Detergent composition |
JP6545822B2 (en) | 2015-04-29 | 2019-07-17 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | Cloth processing method |
CN112143591A (en) | 2015-04-29 | 2020-12-29 | 宝洁公司 | Method for treating fabric |
WO2016176296A1 (en) | 2015-04-29 | 2016-11-03 | The Procter & Gamble Company | Method of laundering a fabric |
CN107532116B (en) | 2015-04-29 | 2021-05-07 | 宝洁公司 | Method for treating fabric |
EP3292173B1 (en) | 2015-05-04 | 2025-03-26 | Milliken & Company | Leuco triphenylmethane colorants as bluing agents in laundry care compositions |
EP3294882B1 (en) | 2015-05-08 | 2021-07-07 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
AR104783A1 (en) | 2015-05-08 | 2017-08-16 | Novozymes As | A-AMYLASE AND POLINUCLEOTIDE VARIANTS CODING THEM |
EP3098296A1 (en) | 2015-05-29 | 2016-11-30 | The Procter and Gamble Company | Process for making a multi-compartment pouch |
EP3098295A1 (en) | 2015-05-29 | 2016-11-30 | The Procter and Gamble Company | Process for making a single or multi-compartment pouch |
EP3124586A1 (en) | 2015-07-29 | 2017-02-01 | The Procter and Gamble Company | Process for reducing malodour in a pack |
ES2728108T3 (en) | 2015-07-29 | 2019-10-22 | Procter & Gamble | Multistage cleaning product in unit dose |
CA3002668A1 (en) | 2015-11-26 | 2017-06-01 | Neil Joseph Lant | Liquid detergent compositions comprising protease and encapsulated lipase |
EP3178917A1 (en) | 2015-12-08 | 2017-06-14 | The Procter and Gamble Company | Cleaning pouch |
EP3181675B2 (en) | 2015-12-17 | 2022-12-07 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
EP3181670B1 (en) | 2015-12-17 | 2019-01-30 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3181678A1 (en) | 2015-12-17 | 2017-06-21 | The Procter and Gamble Company | Process for making a detergent powder |
EP3181679A1 (en) | 2015-12-17 | 2017-06-21 | The Procter and Gamble Company | Process for making an automatic dishwashing product |
EP3181672A1 (en) | 2015-12-17 | 2017-06-21 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3181676B1 (en) | 2015-12-17 | 2019-03-13 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3181671B1 (en) | 2015-12-17 | 2024-07-10 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
EP3184622A1 (en) | 2015-12-22 | 2017-06-28 | The Procter and Gamble Company | Automatic dishwashing composition |
WO2017136370A1 (en) | 2016-02-02 | 2017-08-10 | The Procter & Gamble Company | Compositions containing antifoams |
EP3205392A1 (en) | 2016-02-12 | 2017-08-16 | Basf Se | Microcapsules and process for preparation of microcapsules |
EP3205393A1 (en) | 2016-02-12 | 2017-08-16 | Basf Se | Process for preparation of microcapsules |
EP3228686B1 (en) | 2016-04-08 | 2021-10-27 | The Procter & Gamble Company | Automatic dishwashing |
EP3228690B1 (en) | 2016-04-08 | 2020-05-13 | The Procter and Gamble Company | Automatic dishwashing cleaning composition |
JP2019513860A (en) | 2016-04-08 | 2019-05-30 | ザ プロクター アンド ギャンブル カンパニー | Automatic dishwashing detergent composition |
EP3228687B1 (en) | 2016-04-08 | 2019-05-22 | The Procter and Gamble Company | Dishwashing cleaning composition |
WO2017182295A1 (en) | 2016-04-18 | 2017-10-26 | Basf Se | Liquid cleaning compositions |
WO2017192653A1 (en) | 2016-05-03 | 2017-11-09 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
EP3241890B1 (en) | 2016-05-03 | 2019-06-26 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3241891B1 (en) | 2016-05-03 | 2019-04-03 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3241889B1 (en) | 2016-05-03 | 2019-03-20 | The Procter and Gamble Company | Cleaning composition |
EP3257928B1 (en) | 2016-06-17 | 2019-12-11 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3257931A1 (en) | 2016-06-17 | 2017-12-20 | The Procter and Gamble Company | Detergent composition |
EP3257930A1 (en) | 2016-06-17 | 2017-12-20 | The Procter and Gamble Company | Cleaning pouch |
EP3257923B1 (en) | 2016-06-17 | 2020-04-08 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3257929B1 (en) | 2016-06-17 | 2022-03-09 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
EP3266860B1 (en) | 2016-07-08 | 2020-04-08 | The Procter and Gamble Company | Process for making a particle |
EP3275986B1 (en) | 2016-07-26 | 2020-07-08 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3275989A1 (en) | 2016-07-26 | 2018-01-31 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3275988B1 (en) | 2016-07-26 | 2020-07-08 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3275987A1 (en) | 2016-07-26 | 2018-01-31 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3275985A1 (en) | 2016-07-26 | 2018-01-31 | The Procter and Gamble Company | Automatic dishwashing detergent composition |
EP3290503A3 (en) | 2016-09-01 | 2018-05-30 | The Procter & Gamble Company | Automatic dishwashing cleaning composition |
CN106566820B (en) * | 2016-09-20 | 2019-07-16 | 江南大学 | Preparation method of alpha-amylase |
EP3312265A1 (en) | 2016-10-18 | 2018-04-25 | The Procter and Gamble Company | Detergent composition |
WO2018085315A1 (en) | 2016-11-01 | 2018-05-11 | The Procter & Gamble Company | Leuco colorants as bluing agents in laundry care compositions, packaging, kits and methods thereof |
WO2018085310A1 (en) | 2016-11-01 | 2018-05-11 | The Procter & Gamble Company | Leuco colorants as bluing agents in laundry care compositions |
EP3535319A1 (en) | 2016-11-01 | 2019-09-11 | Milliken & Company | Leuco colorants as bluing agents in laundry care compositions |
US20180119056A1 (en) | 2016-11-03 | 2018-05-03 | Milliken & Company | Leuco Triphenylmethane Colorants As Bluing Agents in Laundry Care Compositions |
US10550443B2 (en) | 2016-12-02 | 2020-02-04 | The Procter & Gamble Company | Cleaning compositions including enzymes |
WO2018102478A1 (en) | 2016-12-02 | 2018-06-07 | The Procter & Gamble Company | Cleaning compositions including enzymes |
DK3330349T3 (en) | 2016-12-02 | 2024-07-15 | Procter & Gamble | CLEANING COMPOSITIONS INCLUDING ENZYMES |
EP3339410A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Automatic dishwashing composition |
EP3339423A1 (en) | 2016-12-22 | 2018-06-27 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
RU2019123965A (en) | 2017-02-01 | 2021-02-01 | Дзе Проктер Энд Гэмбл Компани | CLEANING COMPOSITIONS CONTAINING AMYLASE VERSIONS |
EP3418366A1 (en) | 2017-06-19 | 2018-12-26 | The Procter & Gamble Company | Automatic dishwashing cleaning composition |
EP3418364A1 (en) | 2017-06-19 | 2018-12-26 | The Procter & Gamble Company | Automatic dishwashing cleaning composition |
EP3418365A1 (en) | 2017-06-19 | 2018-12-26 | The Procter & Gamble Company | Automatic dishwashing cleaning composition |
EP3441450A1 (en) | 2017-08-11 | 2019-02-13 | The Procter & Gamble Company | Automatic dishwashing composition |
EP3456808A1 (en) | 2017-09-13 | 2019-03-20 | The Procter & Gamble Company | Automatic dishwashing cleaning composition |
EP3467085A1 (en) | 2017-10-05 | 2019-04-10 | The Procter & Gamble Company | Dishwashing cleaning composition |
EP3467086B1 (en) | 2017-10-05 | 2021-03-24 | The Procter & Gamble Company | Dishwashing cleaning composition |
TWI715878B (en) | 2017-10-12 | 2021-01-11 | 美商美力肯及公司 | Leuco colorants and compositions |
JP6993503B2 (en) | 2017-10-12 | 2022-01-13 | ザ プロクター アンド ギャンブル カンパニー | Leuco colorant as a bluish agent in laundry care compositions |
US20190194579A1 (en) | 2017-10-12 | 2019-06-27 | The Procter & Gamble Company | Leuco colorants as bluing agents in laundry care compositions |
JP6945947B2 (en) | 2017-10-12 | 2021-10-06 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | Leuco colorant combined with a second whitening agent as a bluing agent in the laundry care composition |
BR112020008476B1 (en) | 2017-11-01 | 2023-11-21 | Milliken & Company | LEUCO COMPOUND |
EP3502244B1 (en) | 2017-12-19 | 2025-03-05 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
EP3502246A1 (en) | 2017-12-19 | 2019-06-26 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
EP3502245B1 (en) | 2017-12-19 | 2025-03-05 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
EP3502227B1 (en) | 2017-12-19 | 2024-09-04 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
JP7110355B2 (en) | 2018-01-26 | 2022-08-01 | ザ プロクター アンド ギャンブル カンパニー | Water soluble unit dose articles containing enzymes |
EP3530723B1 (en) | 2018-02-21 | 2023-03-29 | The Procter & Gamble Company | Automatic dishwashing composition |
CA3089284A1 (en) | 2018-02-28 | 2019-09-06 | The Procter & Gamble Company | Methods of cleaning using a glycogen debranching enzyme |
EP3533859A1 (en) | 2018-02-28 | 2019-09-04 | The Procter & Gamble Company | Cleaning compositions |
WO2019245839A1 (en) | 2018-06-19 | 2019-12-26 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
CN112189052A (en) | 2018-06-19 | 2021-01-05 | 宝洁公司 | Automatic dishwashing detergent composition |
CN113508174A (en) | 2019-03-14 | 2021-10-15 | 宝洁公司 | Method for treating cotton |
EP3938484A1 (en) | 2019-03-14 | 2022-01-19 | The Procter & Gamble Company | Cleaning compositions comprising enzymes |
CA3127169A1 (en) | 2019-03-14 | 2020-09-17 | The Procter & Gamble Company | Cleaning compositions comprising enzymes |
EP3741283B1 (en) | 2019-05-22 | 2025-03-19 | The Procter & Gamble Company | Automatic dishwashing method |
EP3976775A1 (en) | 2019-05-24 | 2022-04-06 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
JP7326497B2 (en) | 2019-06-24 | 2023-08-15 | ザ プロクター アンド ギャンブル カンパニー | Cleaning compositions containing amylase variants |
EP3990605A1 (en) | 2019-06-28 | 2022-05-04 | The Procter & Gamble Company | Cleaning composition |
EP3760699A1 (en) | 2019-07-02 | 2021-01-06 | The Procter & Gamble Company | Automatic dishwashing detergent composition |
US11492571B2 (en) | 2019-10-24 | 2022-11-08 | The Procter & Gamble Company | Automatic dishwashing detergent composition comprising a protease |
US20210122998A1 (en) | 2019-10-24 | 2021-04-29 | The Procter & Gamble Company | Automatic dishwashing detergent composition comprising an amylase |
EP3835396A1 (en) | 2019-12-09 | 2021-06-16 | The Procter & Gamble Company | A detergent composition comprising a polymer |
EP3862412A1 (en) | 2020-02-04 | 2021-08-11 | The Procter & Gamble Company | Detergent composition |
WO2021180546A1 (en) | 2020-03-11 | 2021-09-16 | Unilever Ip Holdings B.V. | Low foaming solid cleaning composition |
CA3173147A1 (en) | 2020-06-05 | 2021-12-09 | Phillip Kyle Vinson | Detergent compositions containing a branched surfactant |
CA3186847A1 (en) | 2020-08-04 | 2022-02-10 | Nevena Lukic | Automatic dishwashing method |
WO2022031309A1 (en) | 2020-08-04 | 2022-02-10 | The Procter & Gamble Company | Automatic dishwashing method |
CA3187725A1 (en) | 2020-08-04 | 2022-02-10 | The Procter & Gamble Company | Automatic dishwashing method |
CA3187735A1 (en) | 2020-08-04 | 2022-02-10 | Nina Elizabeth GRAY | Automatic dishwashing method and pack |
EP4204527B1 (en) | 2020-08-26 | 2024-02-14 | Unilever IP Holdings B.V. | Detergent composition comprising isethionate surfactant |
EP3974504B1 (en) | 2020-09-29 | 2023-07-26 | The Procter & Gamble Company | Automatic dishwashing cleaning composition |
EP4237498A1 (en) | 2020-10-27 | 2023-09-06 | Milliken & Company | Compositions comprising leuco compounds and colorants |
CN116348580A (en) | 2020-10-29 | 2023-06-27 | 宝洁公司 | Cleaning compositions containing alginic acid enzyme |
WO2022108611A1 (en) | 2020-11-17 | 2022-05-27 | The Procter & Gamble Company | Automatic dishwashing method with alkaline rinse |
WO2022108764A1 (en) | 2020-11-17 | 2022-05-27 | The Procter & Gamble Company | Automatic dishwashing composition |
EP4001387A1 (en) | 2020-11-17 | 2022-05-25 | The Procter & Gamble Company | Automatic dishwashing composition commprising amphiphilic graft polymer |
EP4001388A1 (en) | 2020-11-17 | 2022-05-25 | The Procter & Gamble Company | Automatic dishwashing method with amphiphilic graft polymer in the rinse |
EP4006131A1 (en) | 2020-11-30 | 2022-06-01 | The Procter & Gamble Company | Method of laundering fabric |
JP7605987B2 (en) | 2020-12-23 | 2024-12-24 | ビーエーエスエフ ソシエタス・ヨーロピア | Amphiphilic alkoxylated polyamines and their uses |
CA3199985A1 (en) | 2021-03-15 | 2022-09-22 | Lars Lehmann Hylling Christensen | Cleaning compositions containing polypeptide variants |
EP4095223A1 (en) | 2021-05-05 | 2022-11-30 | The Procter & Gamble Company | Methods for making cleaning compositions and for detecting soils |
EP4086330A1 (en) | 2021-05-06 | 2022-11-09 | The Procter & Gamble Company | Surface treatment |
EP4108767A1 (en) | 2021-06-22 | 2022-12-28 | The Procter & Gamble Company | Cleaning or treatment compositions containing nuclease enzymes |
EP4108150B1 (en) | 2021-06-22 | 2024-10-16 | The Procter & Gamble Company | A method of treating dishware in a domestic automatic dishwashing machine |
EP4123006A1 (en) | 2021-07-19 | 2023-01-25 | The Procter & Gamble Company | Composition comprising spores and pro-perfume materials |
EP4123007A1 (en) | 2021-07-19 | 2023-01-25 | The Procter & Gamble Company | Fabric treatment using bacterial spores |
WO2023017794A1 (en) | 2021-08-10 | 2023-02-16 | 株式会社日本触媒 | Polyalkylene-oxide-containing compound |
EP4416255A1 (en) | 2021-10-14 | 2024-08-21 | The Procter & Gamble Company | A fabric and home care product comprising cationic soil release polymer and lipase enzyme |
EP4194536A1 (en) | 2021-12-08 | 2023-06-14 | The Procter & Gamble Company | Laundry treatment cartridge |
EP4194537A1 (en) | 2021-12-08 | 2023-06-14 | The Procter & Gamble Company | Laundry treatment cartridge |
CA3240641A1 (en) | 2021-12-16 | 2023-06-22 | Michelle Jackson | Automatic dishwashing composition comprising a protease |
US20230265358A1 (en) | 2021-12-16 | 2023-08-24 | The Procter & Gamble Company | Home care composition comprising an amylase |
US20230365897A1 (en) | 2021-12-16 | 2023-11-16 | The Procter & Gamble Company | Fabric and home care composition including a protease |
WO2023114793A1 (en) | 2021-12-16 | 2023-06-22 | The Procter & Gamble Company | Home care composition |
EP4273209A1 (en) | 2022-05-04 | 2023-11-08 | The Procter & Gamble Company | Machine-cleaning compositions containing enzymes |
EP4273210A1 (en) | 2022-05-04 | 2023-11-08 | The Procter & Gamble Company | Detergent compositions containing enzymes |
EP4279571A1 (en) | 2022-05-19 | 2023-11-22 | The Procter & Gamble Company | Laundry composition comprising spores |
EP4286500A1 (en) | 2022-06-01 | 2023-12-06 | The Procter & Gamble Company | Use of xylanase in a dishwashing process |
EP4286501B1 (en) | 2022-06-01 | 2025-01-08 | The Procter & Gamble Company | Dishwashing detergent composition comprising xylanase and block co-polymer |
EP4286499A1 (en) | 2022-06-01 | 2023-12-06 | The Procter & Gamble Company | Dishwashing detergent composition comprising xylanase and sulphonated carboxylate polymer |
EP4321604A1 (en) | 2022-08-08 | 2024-02-14 | The Procter & Gamble Company | A fabric and home care composition comprising surfactant and a polyester |
EP4339271A1 (en) | 2022-09-16 | 2024-03-20 | The Procter & Gamble Company | Methods and apparatuses for automatic dishwashing chemical distribution |
EP4361061A1 (en) | 2022-10-26 | 2024-05-01 | The Procter & Gamble Company | Detergent product |
WO2024094778A1 (en) | 2022-11-04 | 2024-05-10 | Clariant International Ltd | Polyesters |
WO2024094790A1 (en) | 2022-11-04 | 2024-05-10 | Clariant International Ltd | Polyesters |
WO2024094785A1 (en) | 2022-11-04 | 2024-05-10 | Clariant International Ltd | Polyesters |
WO2024119298A1 (en) | 2022-12-05 | 2024-06-13 | The Procter & Gamble Company | Fabric and home care composition comprising a polyalkylenecarbonate compound |
WO2024129520A1 (en) | 2022-12-12 | 2024-06-20 | The Procter & Gamble Company | Fabric and home care composition |
EP4386074A1 (en) | 2022-12-16 | 2024-06-19 | The Procter & Gamble Company | Fabric and home care composition |
EP4388967A1 (en) | 2022-12-19 | 2024-06-26 | The Procter & Gamble Company | Dishwashing method |
WO2024151573A1 (en) | 2023-01-09 | 2024-07-18 | The Procter & Gamble Company | Superposed multi-sectioned water-soluble unit dose automatic dishwashing detergent pouch |
US20240263162A1 (en) | 2023-02-01 | 2024-08-08 | The Procter & Gamble Company | Detergent compositions containing enzymes |
EP4458932A1 (en) | 2023-05-04 | 2024-11-06 | The Procter & Gamble Company | A fabric and home care composition |
EP4458933A1 (en) | 2023-05-05 | 2024-11-06 | The Procter & Gamble Company | A fabric and home care composition comprising a propoxylated polyol |
EP4481027A1 (en) | 2023-06-19 | 2024-12-25 | The Procter & Gamble Company | Cleaning compositions containing enzymes |
EP4484536A1 (en) | 2023-06-26 | 2025-01-01 | The Procter & Gamble Company | Fabric and home care composition |
EP4488351A1 (en) | 2023-07-03 | 2025-01-08 | The Procter & Gamble Company | Compositions containing a porphyrin binding protein |
EP4549541A1 (en) | 2023-11-02 | 2025-05-07 | The Procter & Gamble Company | Fabric and home care composition |
EP4549540A1 (en) | 2023-11-02 | 2025-05-07 | The Procter & Gamble Company | Fabric and home care composition |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5635468A (en) * | 1993-05-19 | 1997-06-03 | Kao Corporation | Liquefying alkaline α-amylase, process for producing the same, and detergent composition containing the same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0165550B1 (en) * | 1989-06-29 | 1999-01-15 | 마가렛트 에이. 호른 | Mutant microbial amylases with increased thermal acid and/or alkaline stability |
DE69534464T2 (en) | 1994-03-29 | 2006-09-28 | Novozymes A/S | ALKALIC AMYLASE FROM BACELLUS |
-
1995
- 1995-06-14 JP JP7147257A patent/JP3025627B2/en not_active Expired - Fee Related
-
1996
- 1996-06-14 EP EP96917693A patent/EP0833927B1/en not_active Expired - Lifetime
- 1996-06-14 DK DK96917693T patent/DK0833927T3/en active
- 1996-06-14 DE DE69636475T patent/DE69636475T2/en not_active Expired - Lifetime
- 1996-06-14 CN CN96194754A patent/CN1128221C/en not_active Expired - Fee Related
- 1996-06-14 WO PCT/JP1996/001641 patent/WO1997000324A1/en active IP Right Grant
- 1996-06-14 US US08/952,741 patent/US6979731B1/en not_active Expired - Fee Related
-
2001
- 2001-11-09 US US09/986,676 patent/US6638748B2/en not_active Expired - Fee Related
-
2004
- 2004-04-22 US US10/829,331 patent/US20080050807A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5635468A (en) * | 1993-05-19 | 1997-06-03 | Kao Corporation | Liquefying alkaline α-amylase, process for producing the same, and detergent composition containing the same |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011005932A1 (en) | 2009-07-10 | 2011-01-13 | The Procter & Gamble Company | Compositions containing benefit agent delivery particles |
WO2011005943A1 (en) | 2009-07-10 | 2011-01-13 | The Procter & Gamble Company | Compositions containing benefit agent delivery particles |
US20110021408A1 (en) * | 2009-07-10 | 2011-01-27 | Michelle Meek | Compositions containing benefit agent delivery particles |
EP3336164A1 (en) | 2009-07-10 | 2018-06-20 | The Procter & Gamble Company | Compositions containing benefit agent delivery particles |
Also Published As
Publication number | Publication date |
---|---|
EP0833927A1 (en) | 1998-04-08 |
DK0833927T3 (en) | 2006-11-13 |
CN1128221C (en) | 2003-11-19 |
EP0833927B1 (en) | 2006-08-23 |
JPH08336392A (en) | 1996-12-24 |
DE69636475T2 (en) | 2007-05-03 |
CN1187853A (en) | 1998-07-15 |
DE69636475D1 (en) | 2006-10-05 |
JP3025627B2 (en) | 2000-03-27 |
US6638748B2 (en) | 2003-10-28 |
US20020102698A1 (en) | 2002-08-01 |
WO1997000324A1 (en) | 1997-01-03 |
US6979731B1 (en) | 2005-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6979731B1 (en) | Gene encoding alkaline liquefying α-amylase | |
US6403355B1 (en) | Amylases | |
Ferrari et al. | Commercial production of extracellular enzymes | |
CA2452029C (en) | A group of .alpha.-amylases and a method for identification and production of .alpha.-amylases | |
JPH06217770A (en) | Pullulanase, microorganism producing the same, preparation method and use of the pullulanase | |
JP4426716B2 (en) | High productivity α-amylase | |
US20090226961A1 (en) | Mutant alpha-amylases | |
WO1998013481A1 (en) | An enzyme with amylase activity | |
CA2231843A1 (en) | Alkaliphilic and thermophilic microorganisms and enzymes obtained therefrom | |
Lo et al. | Deletion analysis of the C-terminal region of the α-amylase of Bacillus sp. strain TS-23 | |
EP1002062B1 (en) | Starch conversion process using thermostable isoamylases from sulfolobus | |
US6338959B1 (en) | Gene for enzyme having both alkaline pullulanase and alkaline α-amylase activities | |
JP4077095B2 (en) | New amylase | |
JP4417532B2 (en) | Mutant α-amylase | |
JP4372986B2 (en) | Alkaline pullulanase | |
EP0640138B1 (en) | Dna fragment containing gene for alkaline pullulanase | |
US6921656B1 (en) | Polypeptides having glucoamylase activity | |
JP4358984B2 (en) | Alkaline cellulase gene | |
Kang et al. | Cloning, sequencing, characterization, and expression of a new α-amylase isozyme gene (amy3) from Pseudomonas sp. | |
Kobayashi et al. | Novel and useful enzymes from deep-sea and deep-subsurface microorganisms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |